Sanofi and As­traZeneca to make 230,000 ad­di­tion­al RSV im­mu­niza­tions avail­able, White House says

RSV vac­cine man­u­fac­tur­ers Sanofi and As­traZeneca will make 230,000 more dos­es of their im­mu­niza­tions for in­fants avail­able be­gin­ning in Jan­u­ary to ad­dress high de­mand, the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER